Published in Blood on September 24, 2012
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Invest (2013) 2.03
Wnt/β-catenin signaling pathway may regulate the expression of angiogenic growth factors in hepatocellular carcinoma. Oncol Lett (2014) 1.01
Tumor-infiltrating myeloid cells activate Dll4/Notch/TGF-β signaling to drive malignant progression. Cancer Res (2014) 0.99
Endothelial RAF1/ERK activation regulates arterial morphogenesis. Blood (2013) 0.92
Crim1 maintains retinal vascular stability during development by regulating endothelial cell Vegfa autocrine signaling. Development (2013) 0.89
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells. Oncotarget (2015) 0.83
Proangiogenic Function of T Cells in Corneal Transplantation. Transplantation (2016) 0.82
EphrinB2 controls vessel pruning through STAT1-JNK3 signalling. Nat Commun (2015) 0.80
Sema3A maintains corneal avascularity during development by inhibiting Vegf induced angioblast migration. Dev Biol (2014) 0.80
VEGF induces sensory and motor peripheral plasticity, alters bladder function, and promotes visceral sensitivity. BMC Physiol (2012) 0.79
Nox4 supports proper capillary growth in exercise and retina neo-vascularization. J Physiol (2015) 0.78
The discovery of angiogenic growth factors: the contribution of Italian scientists. Vasc Cell (2014) 0.77
GRANULOCYTE INFILTRATION AND EXPRESSION OF THE PRO-ANGIOGENIC BV8 PROTEIN IN EXPERIMENTAL EL4 AND LEWIS LUNG CARCINOMA TUMORS. Cureus (2013) 0.77
Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis. BMC Syst Biol (2015) 0.77
Transmembrane semaphorins: Multimodal signaling cues in development and cancer. Cell Adh Migr (2016) 0.76
The role of the semaphorins in cancer. Cell Adh Migr (2016) 0.75
Nrf2 in ischemic neurons promotes retinal vascular regeneration through regulation of semaphorin 6A. Proc Natl Acad Sci U S A (2015) 0.75
Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer (2010) 8.55
Autocrine VEGF signaling is required for vascular homeostasis. Cell (2007) 7.37
Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat Genet (2001) 5.67
Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell (2003) 4.42
Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell (1999) 3.84
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature (2003) 3.42
Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature (2001) 3.07
Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol (1999) 3.00
Semaphorin regulation of cellular morphology. Annu Rev Cell Dev Biol (2007) 2.96
The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer (2008) 2.95
Development of the retinal vasculature. Angiogenesis (2007) 2.93
G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc Natl Acad Sci U S A (2009) 2.68
Development and pathology of the hyaloid, choroidal and retinal vasculature. Int J Dev Biol (2004) 2.56
Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell (1993) 2.39
Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23~27~24 clusters. Proc Natl Acad Sci U S A (2011) 2.10
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood (2008) 1.93
Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. Nature (2011) 1.89
Plexin-a4 mediates axon-repulsive activities of both secreted and transmembrane semaphorins and plays roles in nerve fiber guidance. J Neurosci (2005) 1.89
Generation of HIV-1 derived lentiviral vectors. Methods Enzymol (2002) 1.81
Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS. Nature (2009) 1.75
Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin. J Cell Sci (2009) 1.74
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest (2008) 1.68
Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers. Neuron (2007) 1.66
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest (2009) 1.56
Plexin-A2 and its ligand, Sema6A, control nucleus-centrosome coupling in migrating granule cells. Nat Neurosci (2008) 1.44
Selective requirements for NRP1 ligands during neurovascular patterning. Development (2007) 1.41
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. J Clin Invest (2008) 1.39
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood (2009) 1.38
MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood (2011) 1.37
The transmembrane semaphorin Sema6A controls cerebellar granule cell migration. Nat Neurosci (2005) 1.37
Structural basis for semaphorin signalling through the plexin receptor. Nature (2010) 1.33
Development of an ischemic tolerance model in a PC12 cell line. J Cereb Blood Flow Metab (2005) 1.25
Semaphorin-6A controls guidance of corticospinal tract axons at multiple choice points. Neural Dev (2008) 1.24
The orthologous human and murine semaphorin 6A-1 proteins (SEMA6A-1/Sema6A-1) bind to the enabled/vasodilator-stimulated phosphoprotein-like protein (EVL) via a novel carboxyl-terminal zyxin-like domain. J Biol Chem (2000) 1.24
A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol (2009) 1.21
A 70 amino acid region within the semaphorin domain activates specific cellular response of semaphorin family members. Neuron (1997) 1.19
Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive. EMBO Rep (2008) 1.11
Ocular neovascularization: a valuable model system. Oncogene (2003) 1.10
Specificity and plasticity of thalamocortical connections in Sema6A mutant mice. PLoS Biol (2009) 1.09
Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood (2011) 1.08
Guidance from above: common cues direct distinct signaling outcomes in vascular and neural patterning. Trends Cell Biol (2009) 1.05
Larval cells become imaginal cells under the control of homothorax prior to metamorphosis in the Drosophila tracheal system. Dev Biol (2008) 1.05
Dll4 activation of Notch signaling reduces tumor vascularity and inhibits tumor growth. Blood (2008) 0.98
Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood (2008) 0.98
Roles of semaphorin-6B and plexin-A2 in lamina-restricted projection of hippocampal mossy fibers. J Neurosci (2010) 0.97
Dorsal turning of motor corticospinal axons at the pyramidal decussation requires plexin signaling. Neural Dev (2008) 0.94
The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-kappaB to mediate survival and anchorage-independent growth of malignant mesothelioma cells. Cancer Res (2009) 0.90
Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry (1996) 0.87
Anti-angiogenic therapy as a cancer treatment paradigm. Curr Med Chem Anticancer Agents (2005) 0.82
Oligo-guanosine nucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood (2010) 0.77
Accurate whole human genome sequencing using reversible terminator chemistry. Nature (2008) 90.20
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell (2008) 3.87
Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation. Cancer Res (2005) 3.63
DJ-1 acts in parallel to the PINK1/parkin pathway to control mitochondrial function and autophagy. Hum Mol Genet (2010) 3.00
Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood (2005) 2.91
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood (2002) 2.90
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med (2010) 2.72
A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat Med (2011) 2.69
Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res (2003) 2.44
Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood (2002) 2.43
Structural grading of foveal hypoplasia using spectral-domain optical coherence tomography a predictor of visual acuity? Ophthalmology (2011) 2.42
Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc Natl Acad Sci U S A (2010) 2.33
Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J Biol Chem (2006) 2.32
Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res (2008) 2.16
Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology (2006) 2.15
Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis (2004) 2.13
Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood (2010) 2.08
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells. Nat Immunol (2013) 1.95
VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci U S A (2009) 1.91
Sex differences in striatal dopamine release in healthy adults. Biol Psychiatry (2006) 1.87
Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst (2011) 1.86
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res (2012) 1.85
The guanine cation radical: investigation of deprotonation states by ESR and DFT. J Phys Chem B (2006) 1.83
Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J (2004) 1.79
G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells. Blood (2006) 1.76
Universal plant DNA barcode loci may not work in complex groups: a case study with Indian berberis species. PLoS One (2010) 1.73
Differential processing of stromal-derived factor-1alpha and stromal-derived factor-1beta explains functional diversity. Blood (2003) 1.72
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis (2010) 1.70
VEGF-B inhibits apoptosis via VEGFR-1-mediated suppression of the expression of BH3-only protein genes in mice and rats. J Clin Invest (2008) 1.68
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. Synapse (2008) 1.66
Alterations of central dopamine receptors before and after gastric bypass surgery. Obes Surg (2009) 1.65
Paracrine signaling by platelet-derived growth factor-CC promotes tumor growth by recruitment of cancer-associated fibroblasts. Cancer Res (2009) 1.65
NMR Fourier zeugmatography. 1975. J Magn Reson (2011) 1.64
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors. FASEB J (2002) 1.64
PDGF-D is a potent transforming and angiogenic growth factor. Oncogene (2003) 1.63
Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano (2012) 1.62
B cells activated by lipopolysaccharide, but not by anti-Ig and anti-CD40 antibody, induce anergy in CD8+ T cells: role of TGF-beta 1. J Immunol (2003) 1.56
Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol Cell Biol (2010) 1.50
Tyrosine sulfation: an increasingly recognised post-translational modification of secreted proteins. N Biotechnol (2009) 1.45
Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis. Arch Neurol (2009) 1.42
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci U S A (2013) 1.41
Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology (2002) 1.41
Single-file diffusion of confined water inside SWNTs: an NMR study. ACS Nano (2010) 1.38
EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood (2009) 1.38
SUMOylation participates in induction of ischemic tolerance. J Neurochem (2009) 1.38
Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes (2011) 1.37
Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood (2004) 1.33
Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J Exp Med (2010) 1.33
Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. Am J Pathol (2003) 1.33
The functional significance of foveal abnormalities in albinism measured using spectral-domain optical coherence tomography. Ophthalmology (2011) 1.32
11C-JHU75528: a radiotracer for PET imaging of CB1 cannabinoid receptors. J Nucl Med (2006) 1.32
Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J Neurosci (2006) 1.32
Application of plasmonic bowtie nanoantenna arrays for optical trapping, stacking, and sorting. Nano Lett (2012) 1.31
Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells. Blood (2003) 1.31
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology (2007) 1.30
Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol Cell Biol (2010) 1.28
Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage. PLoS One (2011) 1.28
Increased viral replication in simian immunodeficiency virus/simian-HIV-infected macaques with self-administering model of chronic alcohol consumption. J Acquir Immune Defic Syndr (2005) 1.28
Canonical transient receptor potential 1 plays a role in basic fibroblast growth factor (bFGF)/FGF receptor-1-induced Ca2+ entry and embryonic rat neural stem cell proliferation. J Neurosci (2005) 1.27
Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1alpha in the circulation. Blood (2005) 1.27
High-resolution in vivo imaging in achromatopsia. Ophthalmology (2011) 1.27
Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. & Enterobacter spp. from five Indian Medical Centers. Indian J Med Res (2012) 1.27
Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood (2006) 1.25
Retracted Role of casein phosphopeptide amorphous calcium phosphate in remineralization of white spot lesions and inhibition of Streptococcus mutans? J Conserv Dent (2013) 1.25
Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J Virol (2004) 1.24
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. Blood (2013) 1.23
EphB2 and EphB4 receptors forward signaling promotes SDF-1-induced endothelial cell chemotaxis and branching remodeling. Blood (2006) 1.23
Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus. J Virol (2004) 1.23
Effect of base stacking on the acid-base properties of the adenine cation radical [A*+] in solution: ESR and DFT studies. J Am Chem Soc (2008) 1.22
A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol (2009) 1.21
Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun (2005) 1.20
In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: quantification of labeled cell phenotype. Neuroimage (2008) 1.20
The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain (2007) 1.19
Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis. Haematologica (2010) 1.19
Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology (2006) 1.18
Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data. Adv Exp Med Biol (2003) 1.18
Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis. J Immunol (2011) 1.18
In silico identification of candidate drug and vaccine targets from various pathways in Neisseria gonorrhoeae. In Silico Biol (2009) 1.17
Impaired recruitment of Grk6 and beta-Arrestin 2 causes delayed internalization and desensitization of a WHIM syndrome-associated CXCR4 mutant receptor. PLoS One (2009) 1.17
Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res (2012) 1.17
Morphine enhances Tat-induced activation in murine microglia. J Neurovirol (2009) 1.16
Transcription factor Gfi-1 induced by G-CSF is a negative regulator of CXCR4 in myeloid cells. Blood (2007) 1.16
Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and management. Nat Clin Pract Oncol (2005) 1.16
Huntington's disease: pathogenesis to animal models. Pharmacol Rep (2010) 1.16
Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress. Neuropsychopharmacology (2007) 1.16
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease. J Neurochem (2007) 1.15
The implications of lighted ureteral stenting in laparoscopic colectomy. JSLS (2002) 1.14
Integrating microRNA and mRNA expression profiles of neuronal progenitors to identify regulatory networks underlying the onset of cortical neurogenesis. BMC Neurosci (2009) 1.14
CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int J Cancer (2010) 1.14
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood (2012) 1.14
Photo-induced hole transfer from base to sugar in DNA: relationship to primary radiation damage. Radiat Res (2006) 1.14
The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis. Cancer Cell (2009) 1.14